Evaluation of ultra low dose CT scans with Iomeron 400 contrast
Official title: Ultra Low Dose CT and Use of Iomeron 400 in PCD-CT
Run by University of Zurich · NCT06360627 · Data updated 2026-11-12
This study is testing if using ultra low dose CT scans with a special contrast dye can help find lung problems like blood clots, cancer, and pneumonia while keeping radiation exposure low.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | University of Zurich Academic / other |
| Locations | 1 site (Zurich) |
| Status | Recruiting |
| Started | February 20, 2023 |
| Main results expected | March 31, 2027 |
| Study ends | December 1, 2027 |
| Registry record updated | April 11, 2024 |
| Trial ID | NCT06360627 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults requiring CT scans for pulmonary nodule detection or pneumonia follow-up.
✕Probably not a fit
Patients under 18 years old or with a BMI over 30 may not benefit from this study due to the exclusion criteria.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the effectiveness of ultra low dose computed tomography (CT) protocols combined with Iomeron 400 contrast for detecting pulmonary conditions such as lung embolism, lung cancer, and pneumonia. The approach aims to minimize radiation exposure while maintaining diagnostic accuracy. Participants will undergo CT scans specifically for pulmonary nodule detection and pneumonia follow-up. The study is designed to assess both the safety and efficacy of these imaging techniques.
Why it matters
Potential benefit: If successful, this study could lead to safer imaging protocols that reduce radiation exposure for patients while effectively diagnosing serious lung conditions.
How similar studies have gone: Other studies have shown promise in using low dose CT protocols, suggesting that this approach may be effective, though the specific combination with Iomeron 400 is less commonly tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * CT SCAN for pulmonary nodule detection/follow up * CT SCAN for pneumonia detection/follow up Exclusion Criteria: * under 18 * BMI over 30
Where it's running
-
University Hospital Zurich - Diagnostic Radiology
Zurich, Switzerland Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Observing oxygenation practices during fiberoptic bronchoscopy
This study looks at how doctors provide oxygen and breathing support to adults during fiberoptic bronchoscopy to better understand current practices.
-
ePRO in advanced lung cancer: emotional distress, brain metastasis, and symptom burden
This study tests how patients with advanced lung cancer—some with brain metastases—report emotional distress and symptoms over time using electronic questionnaires.
-
Respiratory Physiotherapy in Critically Ill Pneumonia Patients
This study tests whether a structured breathing and chest therapy program can change inflammatory biomarkers in adults with pneumonia in the ICU compared to usual care.
-
AI-powered CT help to guide pneumonia care
A multicenter trial tests whether using a chest CT–based AI report to guide care reduces death or need for new organ support in adults with pneumonia.
-
Wintergreen oil inhalation for shortness of breath in pneumonia patients
Hospitals will test whether inhaling wintergreen essential oil helps relieve dyspnea in adults with pneumonia.
-
Urine VOC Test to Detect Lung Cancer in Never Smokers
A urine test that looks for volatile compounds is tested to see if it can help detect lung cancer in adults who have never smoked.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.